BSE filing, NSE: FISCHER. Summary written from the filing by ALFA Finder's alert engine.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹24.79
- Market cap
- ₹1,717 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 57.6×Sector 34.1×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Management Change
Fischer Medical Ventures appointed Mr. Chan Sing En as Independent Director of SG subsidiary FMV Global Innovations, effective 27 Oct 2026. No financial consideration involved.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures' subsidiaries declared dividends totaling ₹26.95 Crore. This update provides financial information regarding subsidiary cash flows to the exchange.
- Value
- ₹26.95 Cr
Other other announcement announcements
All →SPR Auto Technologies Other Announcement
SPR Auto Technologies filed its quarterly QIP monitoring agency report for the quarter ended September 30, 2026. The report found no deviation from the issue objects.
Vahh Chemicals Other Announcement
Vahh Chemicals filed its shareholding pattern for the quarter ended September 30, 2026. Promoters and promoter group hold about 64.63% of total shares.
Maharaja & Speedex India Other Announcement
Maharaja & Speedex India filed its quarterly shareholding pattern as of 18 September 2026 under Regulation 31. It shows promoter and public holdings with no transaction or capital event.
Trio Mercantile & Trading Other Announcement
Trio Mercantile & Trading filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing reports promoter and public holdings only, with no transaction or corporate event.
Pace Digitek Other Announcement
Pace Digitek submitted the Crisil Ratings monitoring agency report for the quarter ended September 30, 2026, on IPO proceeds. The report confirms utilisation is per the offer document, with no deviation from objects.
Valencia India Other Announcement
Valencia India reported no deviation in IPO fund use for six months ended September 2026. The Audit Committee-reviewed Regulation 32 statement was filed with BSE.